Literature DB >> 498112

Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent.

J P McGovren, G L Neil, R H Denlinger, T L Hall, S L Crampton, J A Swenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 498112

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  12 in total

1.  Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trial.

Authors:  D F Moore; T D Brown; M LeBlanc; S Dahlberg; T P Miller; S McClure; R I Fisher
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

2.  Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.

Authors:  T D Brown; P J Goodman; T R Fleming; L H Baker; J S Macdonald
Journal:  Invest New Drugs       Date:  1991-02       Impact factor: 3.850

Review 3.  Anthracycline analogs: the past, present, and future.

Authors:  R B Weiss; G Sarosy; K Clagett-Carr; M Russo; B Leyland-Jones
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Menogaril: a new anthracycline agent entering clinical trials.

Authors:  J P McGovren; K G Nelson; M Lassus; J C Cradock; J Plowman; J P Christopher
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

5.  Menogaril in the treatment of malignant mesothelioma: a phase II study.

Authors:  C A Hudis; D P Kelsen
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

6.  Phase I clinical and pharmacokinetic study of menogaril (7-con-O-methylnogarol) in previously treated patients with acute leukemia.

Authors:  C Mazurek; J P Dutcher; E L Schwartz; S Garl; L Benson; P H Wiernik
Journal:  Invest New Drugs       Date:  1993-11       Impact factor: 3.850

7.  A phase I clinical and pharmacokinetic study of the oral and the oral/intravenous administration of menogaril.

Authors:  G R Weiss; T D Brown; J G Kuhn; D D Von Hoff; R H Earhart; W J Adams; J E Brewer; J D Hosley; D A Kasunic
Journal:  Invest New Drugs       Date:  1993-02       Impact factor: 3.850

8.  Synergistic combination of menogarol and melphalan and other two drug combinations.

Authors:  B K Bhuyan; E G Adams; M Johnson; S L Crampton
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

9.  Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors.

Authors:  M L Zanette; U Tirelli; R Sorio; D Zadro; F Figoli; S Monfardini; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Phase II evaluation of menogaril in patients with advanced hypernephroma.

Authors:  H J Long; M D Hauge; T M Therneau; J C Buckner; S Frytak; R G Hahn
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.